Free Trial

Aimei Health Technology (AFJK) Stock Price, News & Analysis

Aimei Health Technology logo
$12.40 +0.01 (+0.04%)
Closing price 11/13/2026 03:57 PM Eastern
Extended Trading
$12.40 0.00 (0.00%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Aimei Health Technology Stock (NASDAQ:AFJK)

Advanced

Key Stats

Today's Range
$12.35
▼
$12.64
50-Day Range
$11.98
▼
$13.18
52-Week Range
$6.75
▼
$130.37
Volume
1,920 shs
Average Volume
2,567 shs
Market Capitalization
$39.24 million
P/E Ratio
206.62
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Aimei Health Technology Co., Ltd. is a special purpose acquisition company, or SPAC, formed to pursue a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

The company has stated that it intends to focus on opportunities in the healthcare and health technology sectors, including businesses with operations in China. It has not established an operating business of its own and is seeking a company to combine with.

AI Generated. May Contain Errors.

Aimei Health Technology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
17th Percentile Overall Score

AFJK MarketRank™: 
0.83355455269 of 5 stars

Aimei Health Technology scored higher than 17% of companies evaluated by MarketBeat, and ranked 231st out of 243 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aimei Health Technology has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Aimei Health Technology has only been the subject of 1 research reports in the past 90 days.

  • Read more about Aimei Health Technology's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aimei Health Technology is 206.62, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.32.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aimei Health Technology is 206.62, which means that it is trading at a more expensive P/E ratio than the Energy sector average P/E ratio of about 21.19.

  • Percentage of Shares Shorted

    0.05% of the float of Aimei Health Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Aimei Health Technology has a short interest ratio ("days to cover") of 1.46, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aimei Health Technology has recently decreased by 26.84%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Aimei Health Technology does not currently pay a dividend.

  • Dividend Growth

    Aimei Health Technology does not have a long track record of dividend growth.

  • News Sentiment

    Aimei Health Technology has a news sentiment score of 1.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Energy companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Aimei Health Technology this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Aimei Health Technology insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.50% of the stock of Aimei Health Technology is held by insiders.

  • Percentage Held by Institutions

    45.58% of the stock of Aimei Health Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Aimei Health Technology's insider trading history.
Receive AFJK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aimei Health Technology and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AFJK Stock News Headlines

Aimei Health Extends SPAC Deadline, Issues New Note
You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
Aimei Health Technology Co., Ltd
Aimei Health Technology Delays Annual 10-K Filing
See More Headlines

AFJK Stock Analysis - Frequently Asked Questions

Aimei Health Technology's stock was trading at $64.01 at the beginning of the year. Since then, AFJK stock has decreased by 80.6% and is now trading at $12.3950.

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) released its quarterly earnings results on Tuesday, November, 18th. The company reported $0.06 EPS for the quarter.

Aimei Health Technology's top institutional shareholders include First Trust Capital Management L.P. (21.38%).

Shares of AFJK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/13/2026
Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Energy
Industry
Oil, Gas & Consumable Fuels
Sub-Industry
Coal & Consumable Fuels
Current Symbol
NASDAQ:AFJK
Previous Symbol
NASDAQ:AFJK
CIK
1979005
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.06
Trailing P/E Ratio
206.62
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.06 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-10.19%
Return on Assets
2.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.01
Quick Ratio
0.01

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.50 per share
Price / Cash Flow
24.85
Book Value
($1.91) per share
Price / Book
-6.49

Miscellaneous

Outstanding Shares
3,166,000
Free Float
3,087,000
Market Cap
$39.24 million
Optionable
N/A
Beta
0.97
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:AFJK) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners